D-1445-2019 Class II Terminated

Recalled by Zydus Pharmaceuticals USA Inc — Pennington, NJ

FDA drug recall D-1445-2019 was initiated by Zydus Pharmaceuticals USA Inc on May 6, 2019 and is designated Class II. Reason for recall: CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure. The recall status is terminated (terminated Sep 16, 2021). Affected quantity: 3,156 1000-count bottles.

Recall details

Product Type
Drugs
Report Date
Jun 26, 2019
Initiation Date
May 6, 2019
Termination Date
Sep 16, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,156 1000-count bottles

Product description

Pramipexole Dihydrochloride Tablets 0.25 mg, 1000-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India. NDC 68382-197-10

Reason for recall

CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

Distribution pattern

Nationwide in the USA

Code information

Lots: M706803, EXP Jun-19; M713438, EXP Oct-19; M801704, EXP Jan-20; M808306, EXP Jun-20; M812484, EXP Aug-20; M820264, EXP Dec-20

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1445-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1445-2019. Report a data issue: hello@regdatalab.com.